References
- Tebbi CK. Sickle Cell Disease, a Review. Hemato. 2022;3(2):341-366. DOI: 10.3390/hemato3020024
- Thomson AM, McHugh TA, Oron AP, Teply Corey, Lonberg Nikhil, Tella VV, et al. Global, regional, and national prevalence and mortality burden of sickle cell disease, 2000-2021: a systematic analysis from the Global Burden of Disease Study 2021. Lancet Haematol. 2023;10(8):e585-599. DOI: 10.1016/S2352-3026(23)00118-7 DOI: 10.1016/S2352-3026(23)00118-7
- Jastaniah W. Epidemiology of sickle cell disease in Saudi Arabia. Ann Saudi Med. 2011;31(3):289-93. (PMID: 21623060). DOI: 10.5144/0256-4947.2011.289
- Elzorkany K, Alsalman M, AlSahlawi M, Alhedhod A, Almulhim NA, Alsultan NJ, et al. Prevalence and predictors of Sickle Cell Nephropathy A single-center experience. Sci Rep. 2024;14(1):28215. DOI: 10.1038/s41598-024-79345-8
- Tolu SS, Van Doren L. Acute and chronic pain management in patients with sickle cell disease in the modern era: a comprehensive review. Transfus Apher Sci. 2022;61(5):103533. DOI: 10.1016/j.transci.2022.103533
- Bathla T, Lotfollahzadeh S, Quisel M, Mehta M, Malikova M, Chitalia VC. End Organ Affection in Sickle Cell Disease. Cells. 2024;13(11):934. DOI: 10.3390/cells13110934
- Kotila T, Adedapo K, Adedapo A, Oluwasola O, Fakunle E, Brown B. Liver dysfunction in steady state sickle cell disease. Ann Hepatol. 2005;4(4):261-3. DOI: 10.1016/S1665-2681(19)32049-6
- Ebeid FSE, Farghal NB, Aly NH. Spectrum of liver affection in children with sickle cell disease: case series. Egypt Liver J. 2024;14(1):72. DOI: 10.1186/s43066-024-00380-1
- Allali S, Taylor M, Brice J, de Montalembert M. Chronic organ injuries in children with sickle cell disease. Haematologica. 2021;106(6):1535-1544. DOI: 10.3324/haematol.2020.271353
- Adam MA, Adam NK, Mohamed BA. Prevalence of sickle cell disease and sickle cell trait among children admitted to Al Fashir Teaching Hospital North Darfur State, Sudan. BMC Res Notes. 2019;12(1):659. DOI: 10.1186/s13104-019-4682-5
- Al-Qurashi MM, El-Mouzan MI, Al-Herbish AS, Al-Salloum AA, Al-Omar AA. The prevalence of sickle cell disease in Saudi children and adolescents A community-based survey. Saudi Med J. 2008;29(10):1480-3. DOI: 10.4103/0256-4947.55163
- Ali Hazzazi A, Ageeli MH, Alfaqih AM, Ali Jaafari A, Malhan HM, Bakkar MM. Epidemiology and characteristics of sickle cell patients admitted to hospitals in Jazan region, Saudi Arabia. Journal of Applied Hematology. 2020;11(1):10-14. DOI: 10.4103/joah.joah_67_19
- Zuair A Bin, Aldossari S, Alhumaidi R, Alrabiah M, Alshabanat A. The Burden of Sickle Cell Disease in Saudi Arabia: A Single-Institution Large Retrospective Study. Int J Gen Med. 2023;16:161-171. DOI: 10.2147/IJGM.S393233
- Rees DC, Brousse VAM, Brewin JN. Determinants of severity in sickle cell disease. Blood Rev. 2022;56:100983. DOI: 10.1016/j.blre.2022.100983
- Akinsheye I, Alsultan A, Solovieff N, Ngo D, Baldwin CT, Sebastiani P, et al. Fetal hemoglobin in sickle cell anemia. Blood. 2011;118(1):19-27. DOI: 10.1182/blood-2011-03-325258
- Steinberg MH. Fetal Hemoglobin in Sickle Hemoglobinopathies: High HbF Genotypes and Phenotypes. J Clin Med. 2020;9(11):3782. DOI: 10.3390/jcm9113782
- Steinberg MH, Chui DH, Dover GJ, Sebastiani P, Alsultan A. Fetal hemoglobin in sickle cell anemia: a glass half full? Blood. 2014;123(4):481-5. DOI: 10.1182/blood-2013-09-528067
- Allali S, de Montalembert M, Brousse V, Heilbronner C, Taylor M, Brice J, et al. Hepatobiliary complications in children with sickle cell disease: A retrospective review of medical records from 616 patients. J Clin Med. 2019;8(9):1481. DOI: 10.3390/jcm8091481
- Adu EM, Okosun RE, Bini EN, Ophori EA. Effects of the sickle cell (S) gene on serum protein profile. Continental J Biomed Sci. 2012;6(2):1-5.
- Suddle AR. Management of liver complications in sickle cell disease. Hematology Am Soc Hematol Educ Program. 2019;1(6):345-350. DOI: 10.1182/hematology.2019000037
- Akuyam SA, Abubakar A, Lawal N, Yusuf R, Aminu SM, Hassan A, et al. Assessment of biochemical liver function tests in relation to age among steady state sickle cell anemia patients. Niger J Clin Pract. 2017;20(11):1428-1433. DOI: 10.4103/njcp.njcp_14_17
- Almarghalani DA, Alotaibi RA, Alzlami TT, Alhumaidi OF, Alharthi NM, Alboqami FM, et al. Clinical Insights into Sickle Cell Disease: A Comprehensive Multicenter Retrospective Analysis of Clinical Characteristics and Outcomes Across Different Age Groups. J Clin Med. 2024;13(23):7224. DOI: 10.3390/jcm13237224
- Amanor E, Kwarteng A, Larbi A, Fordjour FA, Koranteng KK, Sackey DS, et al. Iron stores in steady-state sickle cell disease children accessing care at a sickle cell disease clinic in Kumasi, Ghana: A cross-sectional study. Health Sci Rep. 2022;5(6):e934. DOI: 10.1002/hsr2.934
- Alkindi S, Panjwani V, Al-Rahbi S, Al-Saidi K, Pathare A V. Iron Overload in Patients With Heavily Transfused Sickle Cell Disease-Correlation of Serum Ferritin With Cardiac T2* MRI (CMRTools), Liver T2* MRI, and R2-MRI (Ferriscan®). Front Med (Lausanne). 2021;8:731102. DOI: 10.3389/fmed.2021.731102